Ledger.Open graph →
SEC Form D · filed December 27, 2022

Xanadu Bio, Inc

Offering
$30.0M
Sold
$12.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
GLADWYNE, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Mark Saltzman · Gladwyne, PADirectorBruce Turner · Gladwyne, PAExec · Director · PromoterTodd Wider · Gladwyne, PAExec · Director · PromoterR. H. Lunsford · Dallas, TXDirectorDavid Robertson · Denver, COExec · Director · PromoterLandon Downs · FULTON, MDExec · Director · PromoterDhruv Patel · Durham, NCExec · Director · PromoterJohn Z. Mansfield · Durham, NCDirectorHarry N. Stebbings · London, United KingdomExec · Director · Promoter

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗